Cargando…
A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
Autores principales: | Yang, Jing, Zhang, Wei, Jia, Lin, Shi, Fei, Cao, Min, Sun, Jichao, Xu, Chengchao, Li, Zhijie, Cheng, Zhiqiang, Zhao, Shan‐Chao, Wang, Jigang, Yang, Chuanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894730/ https://www.ncbi.nlm.nih.gov/pubmed/36732082 http://dx.doi.org/10.1002/ctm2.1109 |
Ejemplares similares
-
Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy
por: Wang, Shuang, et al.
Publicado: (2022) -
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
por: Zhang, Wei, et al.
Publicado: (2022) -
Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy
por: Yang, Zhiqing, et al.
Publicado: (2016) -
The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity
por: Lin, Yingjia, et al.
Publicado: (2017) -
Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation
por: Mathiyalagan, Ramya, et al.
Publicado: (2019)